HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael E Lean Selected Research

Exenatide (Byetta)

1/2022A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael E Lean Research Topics

Disease

1Rheumatoid Arthritis
01/2022
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Neoplasms (Cancer)
01/2022
1Weight Loss (Weight Reduction)
01/2022
1Vascular Diseases (Vascular Disease)
03/2016
1Overweight
03/2016

Drug/Important Bio-Agent (IBA)

1Exenatide (Byetta)FDA Link
01/2022
1LipidsIBA
01/2022
1AnthracyclinesIBA
01/2022
1FlavonoidsIBA
03/2016
1Phenol (Carbolic Acid)FDA Link
03/2016
1PhenolsIBA
03/2016

Therapy/Procedure

1Drug Therapy (Chemotherapy)
01/2022